1.
Lamba JK, Meshinchi S. Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin. Haematologica 2021;106(11):2796-2798; https://doi.org/10.3324/haematol.2021.279043.